gene editing

In this webinar, Cole Cheng and Connie Rich will discuss the advantages of novel miniaturized plasmids for streamlining preclinical and clinical gene therapy development.

Lipid nanoparticles deliver CRISPR tools directly to lung stem cells, offering new therapeutic avenues for treating genetic diseases.

The microbiome is a dynamic environment that can give researchers the inside scoop on health and disease.

Discover how scientists produce CRISPR-edited cell populations.

Even as CRISPR-based tools become a lab staple, scientists strive to tackle the associated technological challenges to improve their efficacy and safety.   

In this webinar, Jacob Lamberth will discuss the critical variables and strategies for revolutionizing gene editing experiments.

An innovative helper plasmid improves adeno-associated virus quality and infectivity.

In this podcast series, scientists discuss the unique ways they employ synthesized DNA libraries in their research. 

Human cells repair RNA breaks induced by a programmable CRISPR system, paving the way for temporary treatments for genetic diseases.

Digital PCR is highly sensitive and precise, making it ideal for detecting rare targets and measuring small-fold changes.

A new approach using two types of recombinases lets scientists insert larger DNA payloads into human pluripotent stem cells faster than ever before. 

Base editors and prime editors help researchers perform more precise in vivo and ex vivo translational research.

Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.

Shondra Pruett-Miller has taken many paths in her career with her love of genome editing always as a guiding light.

Understanding how Cas9 binds off-target sequences can help researchers refine CRISPR-mediated genome editing.

CRISPR-Cas9 editing leads to widespread loss of the targeted chromosome in human T cells, but scientists recently discovered a way to prevent such loss.

CRISPR plasmids provide a robust solution for streamlining human cell transfection workflows.   

Researchers design dual CRISPR treatments to remove HIV DNA and prevent reinfection in vitro.

By editing a mutated immune regulatory gene in patient cells, Rosa Bacchetta brings hope to those suffering from IPEX syndrome.